In COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations, with fewer serious adverse events

Sandra G. Adams, Jay I. Peters

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'In COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations, with fewer serious adverse events'. Together they form a unique fingerprint.

Medicine & Life Sciences